GCDTR Mission

Established in 2016 as a collaboration of Emory University, Morehouse School of Medicine, and the Georgia Institute of Technology, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to promote translation and healthy equity research to impact practice, programs, and policy in Georgia and the Souteastern United States.

Read More....

Events

Transitions of Care Services for High-Risk Patients with Diabetes: Closing Racial Disparities to Improve Morbidity and Mortality

Deirdre James, MD | Monday, July 18th | 12:00 PM – 1:00 PM EST

Registration Link: tinyurl.com/gcdtr-seminar-series

Join us for our next seminar series presentation hosted by the Technologies Advancing Translation and Equity Core, featuring a talk by Deirdre James, MD. Dr. Deirdre James is an Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at the University of Tennessee Health Science Center. She currently serves as the Assistant Dean of Student Academic Affairs and devotes time to the education of trainees across several healthcare professions. Highly active in diabetes related clinical research, she is the primary investigator of two and a sub-investigator on 3 pharmaceutical funded trials.

Contact Us:

gcdtr@emory.edu

PILOT FUNDING

Current Funding Opportunities

 

Micro Grant Rapid Funding Mechanism

The Micro Grant Rapid Funding Mechanism (MGRFM) is a unique competitive opportunity being offered by the Georgia Center for Diabetes Translation Research (GCDTR) to provide timely and critical resources that can be leveraged by investigators for the submission of larger research funding requests. Award amounts will range from $500 to $2,000. The MGRFM grants will support diabetes translation research leading to the submission of an NIH (preferably) or other extramural research funding application that addresses themes encompassed in GCDTR’s research cores (www.gcdtr.org/core-programs/).

Funds are intended to be used to:

  • Enable a new NIH or other extramural application that is expected to be submitted within the next 6 to 12 months
  • Gather data needed for a scored NIH or other extramural application that is currently being revised for resubmission

For more information, click here.

Publications

Incidence and Pathophysiology of Diabetes in South Asian Adults Living in India and Pakistan Compared with US blacks and Whites
Narayan KMV, Kondal D, Kobes S, Staimez LR, Mohan D, Gujral UP, Patel SA, Anjana RM, Shivashankar R, Ali MK, Chang HH, Kadir M, Prabhakaran D, Daya N, Selvin E, Tandon N, Hanson R, Mohan V.
BMJ Open Diabetes Research & Care - 2021;9:3001988.
South Asians (SA) and Pima Indians have high prevalence of diabetes but differ markedly in body size. The pathophysiology of type 2 diabetes in non-obese South Asians may imply the need to investigate strategies at improving insulin secretion for diabetes prevention.

Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks
Unjali P. Gujral, Leslie Johnson, Jannie Nielsen, Priyathama Vellanki, J. Sonya Haw, Georgia M. Davis, Mary Beth Weber, Francisco J. Pasquel
BMJ Open Diabetes Research & Care - 2020 Jul;8(1):e001520.
The authors describe how to respond to the public health crisis focused on diabetes care in the USA. They present strategies to address and evaluate transitions in diabetes care occurring in the immediate short-term (ie, response and mitigation), as well as phases to adapt and enhance diabetes care during the months and years to come while also preparing for future pandemics (ie, recovery, surveillance, and preparedness).

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic
Rodolfo J. Galindo, Grazia Aleppo, David C. Klonoff, Elias K. Spanakis, Shivani Agarwal, Priya Vellanki, Darin E. Olson, Guillermo E. Umpierrez, Georgia M. Davis, Francisco J. Pasquel
Journal of Diabetes Science and Technology - 2020 Jul;14(4):822-832.
In this commentary, the authors analyze the answers to six questions about what is needed to bring CGM into the hospital as a reliable, safe, and effective tool, especially with regard to those patients with COVID-19.

More here